ATLANTA, Sept. 17, 2013 /PRNewswire-USNewswire/ -- The American Cancer Society will provide more people in underserved communities with access to cancer screenings and community-based cancer education thanks to the generosity of Walgreens and its customers. The $6.4 million gift, raised through customers via electronic donations at checkout, will help fund the American Cancer Society's ongoing community-based initiatives aimed at reducing cancer disparities in communities with higher burdens of the disease.
The $6.4 million goes towards the Walgreens Way to Well Commitment® program that helps support the Society's Community Health Advocates implementing Nationwide Grants for Empowerment and Equity (CHANGE) program, which provides grant opportunities to increase breast, cervical and colorectal cancer screening rates in communities with a high burden of cancer. Since 2011, CHANGE has implemented 98 projects within underserved communities across the country; educating nearly 300,000 individuals about cancer risk and prevention, and providing nearly 118,000 cancer screenings.
"The American Cancer Society is committed to finishing the fight against cancer in every community," said John R. Seffrin, Ph.D., chief executive officer of the American Cancer Society. "We are grateful to Walgreens for its support of our lifesaving work, especially in communities that carry a disproportionate burden of cancer."
"Walgreens' purpose is to help people get, stay and live well, and our Way to Well Commitment is dedicated to providing resources that aid with the prevention and detection of today's leading diseases," said John Gremer, director of community affairs at Walgreens. "We'd like to thank our customers for their contributions that help us impact countless people across the country."
The Walgreens Way to Well Commitment&
SOURCE American Cancer Society
Copyright©2012 PR Newswire.
All rights reserved
Related medicine technology :
1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting